| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |